Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWITCH: Sorafenib vs Sunitinib Sequencing in mRCC
NCT00732914Phase 3Completed
- Sponsor
- Sponsor
- Start
- Jan 2009
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sorafenib in renal cell carcinoma (RCC), sponsored by Sponsor. Started Jan 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00732914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00732914.